FAMEWAVE
FameWave is a privately held biopharmaceutical company developing CM-24, a clinical stage monoclonal antibody targeting CEACAM1, a novel immune checkpoint. Kitov is planning initiation of a Phase I/II study in early 2020 to evaluate the safety and efficacy of CM-24 in combination with an anti PD-1 inhibitor.
Similar Organizations
Laurent Pharmaceuticals
Laurent Pharmaceuticals is a private biopharmaceutical company developing a clinical stage, orally-active drug candidate.
OnCusp Therapeutics
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
PharmAkea Therapeutics
PharmAkea is a biopharmaceutical company developing small molecule drug candidates targeting proteins in fibroproliferative diseases.